Evidence map›Paper›PMID 26904511›Full record

ReviewFrontiers in cellular and infection microbiology2016

The Many Faces of IpaB.

Wendy L Picking, William D Picking

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cellular and infection microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Development of a NovelVaccines · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. An Experimental Adult Zebrafish Model forMicrobiology spectrum · 2022
    Article
  8. Article
  9. TheMicroorganisms · 2021
    Review
  10. Structural Insights ofFrontiers in cellular and infection microbiology · 2021
    Article
  11. The T3SS ofMicroorganisms · 2020
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Wendy L PickingDepartment of Pharmaceutical Chemistry, School of Pharmacy, University of Kansas Lawrence, KS, USA.
William D PickingDepartment of Pharmaceutical Chemistry, School of Pharmacy, University of Kansas Lawrence, KS, USA.
University of Kansas · US

Funding

The multiple states of IpaB Shigella type III secretionR01AI099489 · NIAID · UNIVERSITY OF KANSAS LAWRENCE · PI PICKING, WILLIAM D. · 2013 to 2017
$2.2M
NIAID NIH HHS R01 AI099489
6 · The paper itself

Abstract

The type III secretion system (T3SS) is Shigella's most important virulence factor. The T3SS apparatus (T3SA) is comprised of an envelope-spanning basal body and an external needle topped by a tip complex protein called IpaD. This nanomachine is used to deliver effector proteins into host cells to promote pathogen entry. A key component of the matured T3SS needle tip complex is the translocator protein IpaB. IpaB can exist in multiple states when prepared as a recombinant protein, however, it has also been described as having additional roles in Shigella pathogenesis. This mini-review will briefly describe some of the features of IpaB as a T3SS needle tip protein, as a pore-forming translocator protein and as an effector protein. Reflection on the potential importance of the different in vitro states of IpaB on its function and importance in serotype-independent vaccines is also provided.

Indexed as

Antigens, BacterialApoptosisBacterial ProteinsDysentery, BacillaryIntestinal MucosaMacrophagesMolecular ChaperonesShigellaType III Secretion SystemsVirulence FactorsAntigens, BacterialBacterial ProteinsipaB protein, ShigellaIpaD protein, Shigella flexneriIpgC protein, ShigellaMolecular ChaperonesType III Secretion SystemsVirulence Factorsinvasion plasmid antigenIpaBpathogenesisShigellatype III secretion

Identifiers

PMID26904511
PMCPMC4746235
OpenAlexW2290908169

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.